Connection

Jeffrey Jones to Sulfonamides

Back to Details
This is a "connection" page, showing publications Jeffrey Jones has written about Sulfonamides.
Jeffrey Jones
Connection Strength
0.550
Sulfonamides
  1. Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial. Lancet Oncol. 2018 01; 19(1):65-75.
    View in: PubMed
    Score: 0.550
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.